Biocept Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$7.16 |
Market Cap |
$39.1 M |
Shares Outstanding |
18.87 M |
Public Float |
11.58 M |
Address |
5810 Nancy Ridge Drive San Diego California 92121 United States |
Employees | - |
Website | http://www.biocept.com |
Updated | 07/08/2019 |
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. |